Literature DB >> 17962822

Uveitis associated with concurrent administration of rifabutin and lopinavir/ritonavir (Kaletra).

H-C Lin, P-L Lu, C-H Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17962822     DOI： 10.1038/sj.eye.6703016

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

2.  Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients.

Authors:  Seni Kouanda; Henri Gautier Ouedraogo; Kadari Cisse; Tegwinde Rebeca Compaoré; Giorgia Sulis; Serge Diagbouga; Alberto Roggi; Grissoum Tarnagda; Paola Villani; Lassana Sangare; Jacques Simporé; Mario Regazzi; Alberto Matteelli
Journal:  BMC Infect Dis       Date:  2020-06-26       Impact factor: 3.090

3.  Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus.

Authors:  Nicky J Mehtani; Sarah Puryear; Paul Pham; Kelly E Dooley; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2021-07-17       Impact factor: 3.835

Review 4.  Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?

Authors:  Lehlogonolo N F Maphalle; Bozena B Michniak-Kohn; Modupe O Ogunrombi; Oluwatoyin A Adeleke
Journal:  Children (Basel)       Date:  2022-07-27

5.  Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir.

Authors:  Wen-Hsin Cheng; Cheng-Hsien Chang; Po-Liang Lu; Hsien-Chung Lin
Journal:  Taiwan J Ophthalmol       Date:  2014-10-07

6.  Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week.

Authors:  Henri Gautier Ouedraogo; Alberto Matteelli; Giorgia Sulis; Tegwinde Rebeca Compaore; Serge Diagbouga; Simon Tiendrebeogo; Alberto Roggi; Kadari Cisse; Pier Francesco Giorgetti; Paola Villani; Lassana Sangare; Jacques Simpore; Mario Regazzi; Seni Kouanda
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-22       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.